Fig. 2From: The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patientsGenotype frequency of p.Q141K in a pediatric-onset cohort with hyperuricemia/gout (31 subjects, MAF = 38.7%) compared to an adult-onset hyperuricemia/gout (203 subjects, MAF = 21.2%), and a normouricemic control cohort (115 subjects, MAF = 8.5%), and data from the ExAC and 1000 Genome databasesBack to article page